-
Je něco špatně v tomto záznamu ?
Persistent Severe Bradyarrhythmia Following Donepezil Discontinuation in Dementia Patient: A Case Report and Literature Review
Okky Wahyu Firmansyah, Budi Baktijasa Dharmadjati, Rerdin Julario, Chabib Fachry Albab, Pandit Bagus Tri Saputra, Emil Prabowo
Jazyk angličtina Země Česko
Typ dokumentu kazuistiky
- MeSH
- bradykardie * diagnóza terapie MeSH
- demence farmakoterapie komplikace MeSH
- donepezil * aplikace a dávkování škodlivé účinky MeSH
- dospělí MeSH
- elektrokardiografie MeSH
- hrudník diagnostické zobrazování patologie MeSH
- kardiostimulace umělá MeSH
- kazuistiky jako téma MeSH
- lidé MeSH
- nenasazení léčby MeSH
- synkopa etiologie MeSH
- závrať etiologie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
Background: Donepezil is an acetylcholinesterase inhibitor used in Alzheimer's disease management. It improves clinical symptoms but carries risks of orthostatic hypotension and bradycardia. Uncommon severe bradyarrhythmias post-discontinuation deserve attention. In addition, there have been no previous case reports regarding severe bradyarrhythmias post donepezil discontinuation. Case presentation: We report a case of a 33-year-old woman with a history of recurrent fainting. She has dementia and regularly takes donepezil. She experienced severe bradyarrhythmia with heart rate of 45 beats per minute regular on dopamine 5 μg/kg/min and unresponsive to atropine. The discontinuation of donepezil did not improve asymptomatic bradycardia. The use of temporary pacemaker (TPM) improved the patient's condition, then permanent pacemaker (PPM) was implanted. Conclusions: This case report highlights donepezil's link to severe bradyarrhythmia in dementia patients. It stresses the challenges in managing adverse effects, suggesting that stopping donepezil and anticholinergic therapy may not always be sufficient and pacemaker implantation may be required.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25006911
- 003
- CZ-PrNML
- 005
- 20250529223414.0
- 007
- ta
- 008
- 250422s2025 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33678/cor.2024.060 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng $b cze
- 044 __
- $a xr
- 100 1_
- $a Firmansyah, Okky Wahyu $u Department of Cardiology and Vascular Medicine, Airlangga University, Surabaya, Indonesia
- 245 10
- $a Persistent Severe Bradyarrhythmia Following Donepezil Discontinuation in Dementia Patient: A Case Report and Literature Review / $c Okky Wahyu Firmansyah, Budi Baktijasa Dharmadjati, Rerdin Julario, Chabib Fachry Albab, Pandit Bagus Tri Saputra, Emil Prabowo
- 520 3_
- $a Background: Donepezil is an acetylcholinesterase inhibitor used in Alzheimer's disease management. It improves clinical symptoms but carries risks of orthostatic hypotension and bradycardia. Uncommon severe bradyarrhythmias post-discontinuation deserve attention. In addition, there have been no previous case reports regarding severe bradyarrhythmias post donepezil discontinuation. Case presentation: We report a case of a 33-year-old woman with a history of recurrent fainting. She has dementia and regularly takes donepezil. She experienced severe bradyarrhythmia with heart rate of 45 beats per minute regular on dopamine 5 μg/kg/min and unresponsive to atropine. The discontinuation of donepezil did not improve asymptomatic bradycardia. The use of temporary pacemaker (TPM) improved the patient's condition, then permanent pacemaker (PPM) was implanted. Conclusions: This case report highlights donepezil's link to severe bradyarrhythmia in dementia patients. It stresses the challenges in managing adverse effects, suggesting that stopping donepezil and anticholinergic therapy may not always be sufficient and pacemaker implantation may be required.
- 650 07
- $a dospělí $7 D000328 $2 czmesh
- 650 07
- $a ženské pohlaví $7 D005260 $2 czmesh
- 650 07
- $a lidé $7 D006801 $2 czmesh
- 650 17
- $a bradykardie $x diagnóza $x terapie $7 D001919 $2 czmesh
- 650 17
- $a donepezil $x aplikace a dávkování $x škodlivé účinky $7 D000077265 $2 czmesh
- 650 07
- $a nenasazení léčby $7 D028761 $2 czmesh
- 650 07
- $a demence $x farmakoterapie $x komplikace $7 D003704 $2 czmesh
- 650 07
- $a kardiostimulace umělá $7 D002304 $2 czmesh
- 650 07
- $a synkopa $x etiologie $7 D013575 $2 czmesh
- 650 07
- $a závrať $x etiologie $7 D004244 $2 czmesh
- 650 07
- $a hrudník $x diagnostické zobrazování $x patologie $7 D013909 $2 czmesh
- 650 07
- $a elektrokardiografie $7 D004562 $2 czmesh
- 650 07
- $a kazuistiky jako téma $7 D000094143 $2 czmesh
- 655 07
- $a kazuistiky $7 D002363 $2 czmesh
- 700 1_
- $a Dharmadjati, Budi Baktijasa $u Department of Cardiology and Vascular Medicine, Airlangga University, Surabaya, Indonesia
- 700 1_
- $a Julario, Rerdin $u Department of Cardiology and Vascular Medicine, Airlangga University, Surabaya, Indonesia
- 700 1_
- $a Albab, Chabib Fachry $u Faculty of Medicine, Airlangga University, Surabaya, Indonesia
- 700 1_
- $a Bagus Tri Saputra, Pandit $u Department of Cardiology and Vascular Medicine, Airlangga University, Surabaya, Indonesia
- 700 1_
- $a Prabowo, Emil $u Department of Cardiology and Vascular Medicine, Airlangga University, Surabaya, Indonesia
- 773 0_
- $t Cor et Vasa $x 0010-8650 $g Roč. 67, č. 1 (2025), s. 60-65 $w MED00010972
- 856 41
- $u https://e-coretvasa.cz/en/artkey/cor-202501-0009_persistent-severe-bradyarrhythmia-following-donepezil-discontinuation-in-dementia-patient-a-case-report-and-li.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 2980 $c 438 $y p $z 0
- 990 __
- $a 20250311 $b ABA008
- 991 __
- $a 20250529223413 $b ABA008
- 999 __
- $a ok $b bmc $g 2307920 $s 1243976
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2025 $b 67 $c 1 $d 60-65 $e 20250301 $i 0010-8650 $m Cor et Vasa $x MED00010972
- LZP __
- $c NLK189 $d 20250529 $b NLK111 $a Actavia-MED00010972-20250311